In vitro activity of ceftazidime-avibactam, imipenem-cilastatin-relebactam, meropenem-vaborbactam, cefiderocol, and plazomicin against non-fermenting Gram-negative isolates obtained from Bulgarian inpatients.

Zavicefta (ceftazidime/avibactam) - Pfizer, AbbVie

Vabomere (meropenem/vaborbactam) - Melinta Therap, Menarini

Fetroja (cefiderocol) - Shionogi

Zemdri (plazomicin) - Ionis, Achaogen

Recarbrio (relebactam/imepenem/cilastatin) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42043870

Alexander Stratev; Emma Keuleyan; Nikolay Kalvatchev; Slavil Peykov; Tanya Strateva

Apr 27, 2026